The Latest Breaking News from FDA

DNA tests find blackchin tilapia in cans

DNA tests have confirmed that fish found in canned products seized from a factory in Samut Sakhon were blackchin tilapia, an invasive species, rather than Nile tilapia as the government previously claimed, opposition lawmakers and the BioThai Foundation said on Tuesday.

Bangkok Post · Jul 14

Trust in the FDA is collapsing. It's time to get really transparent about our food and our drugs

Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build is draining out in two years.

Fortune · Jul 14

A Bacterium from Japanese Tree Frogs Wiped Out Colorectal Tumors in Mice with a Single Dose

Scientists found that Ewingella americana from Japanese tree frogs eliminated 100% of colorectal tumors in mice with a single dose, outperforming chemo and immunotherapy. Pre-clinical only.

Medical Daily · Jul 14

New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss

A March 2026 analysis of 30M+ FDA adverse event reports found Wegovy's NAION eye stroke signal was nearly 5x stronger than Ozempic's. Vision loss may be sudden and permanent.

Medical Daily · Jul 13

FDA Set to Decide on a New Non-Stimulant ADHD Drug for Children and Adults on July 24

FDA decides on centanafadine July 24, 2026 — a first-in-class non-stimulant ADHD drug for children, adolescents, and adults. Four Phase 3 trials support the application.

Medical Daily · Jul 13

There’s one reason why so many cold and flu tablets don’t actually work

You’ve got the sniffles and your nose is running like a tap. The tissues feel like sandpaper.

The Conversation · Jul 13

Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers

Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer's, and frailty. Here is an honest account of what 80-plus trials are finding.

Medical Daily · Jul 13

The First Human Trial to Reverse Aging Just Got FDA Clearance: What Epigenetic Reprogramming Actually Is

Harvard geneticist David Sinclair's Life Biosciences received FDA approval in January 2026 to begin the world's first human trial of partial epigenetic reprogramming — a technology that has already reversed aging in mouse and primate eyes. Here is what the science actually shows, and what it does not yet prove.

Medical Daily · Jul 13

A Breast Cancer Drug Decision Due July 17 Could Open a New Treatment Path for 37,000 Women a Year Who Have No Good Options Now

FDA decides on gedatolisib July 17, 2026, for HR+/HER2-/PIK3CA wild-type advanced breast cancer. A Phase 3 trial showed 76% risk reduction in progression. 37,000 patients per year.

Medical Daily · Jul 13

"40% Analog paneer samples found unsafe," says MH FDA Commissioner Tukaram Mundhe

Maharashtra FDA is intensifying action against adulterated milk products. Milk and dairy items are considered high-risk food categories requiring strict monitoring. The FDA is implementing end-to-end supply chain management for milk products. Action includes closing centers, destroying milk, and prosecuting violators. Substandard analog paneer and cheese also face strict regulatory…

The Economic Times · Jul 13